Marx, K.; Malmström, N.; Quast, M.; Glas, A.; Wendt, R.; Kinzig, M.; Sörgel, F.; Fedders, M.; Bertsche, T.; Lübbert, C.
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study. Antibiotics 2025, 14, 548.
https://doi.org/10.3390/antibiotics14060548
AMA Style
Marx K, Malmström N, Quast M, Glas A, Wendt R, Kinzig M, Sörgel F, Fedders M, Bertsche T, Lübbert C.
Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study. Antibiotics. 2025; 14(6):548.
https://doi.org/10.3390/antibiotics14060548
Chicago/Turabian Style
Marx, Kathrin, Nina Malmström, Marie Quast, Annette Glas, Ralph Wendt, Martina Kinzig, Fritz Sörgel, Maike Fedders, Thilo Bertsche, and Christoph Lübbert.
2025. "Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study" Antibiotics 14, no. 6: 548.
https://doi.org/10.3390/antibiotics14060548
APA Style
Marx, K., Malmström, N., Quast, M., Glas, A., Wendt, R., Kinzig, M., Sörgel, F., Fedders, M., Bertsche, T., & Lübbert, C.
(2025). Monitoring Plasma Concentrations of Intravenously Administered Fosfomycin to Prevent Drug-Related Adverse Events: A Retrospective Observational Study. Antibiotics, 14(6), 548.
https://doi.org/10.3390/antibiotics14060548
